Balancing Clinical and Economic Factors in Early Breast Cancer Treatment


The panelists discuss the clinical and economic factors that influence treatment decisions for early breast cancer (eBC), as well as the differences between eBC and metastatic breast cancer (mBC) in terms of adverse event management protocols and strategies for optimizing patient adherence.

Video content above is prompted by the following questions:

  • What is the current standard of care for early breast cancer?
    • What role do academic and community pharmacists have in the treatment plan?
    • What are the clinical and economic considerations that go into deciding on a treatment option for eBC?
  • What is the difference between eBC and mBC in terms of AE protocols and adherence optimization?
    • Can any mBC practices apply to eBC?
Related Videos
A panel of 4 experts on breast cancer
A panel of 4 experts on breast cancer
Video 14 - "Closing Remarks on RSV Vaccinations"
Video 13 - "Understanding RSV Infection Patterns and Seasonal Outbreaks"
A panel of 4 experts on breast cancer
A panel of 4 experts
A panel of 4 experts
Video 12 - "Empowering RSV Patients: Essential Vaccine Education Resources"
Video 11 - "Unmet Needs in Prevention and Management of RSV"
Video 9 - "Unmet Needs in Relapsed or Refractory Multiple Myeloma"
© 2024 MJH Life Sciences

All rights reserved.